These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 27797809)

  • 21. Neurons selectively targeted in frontotemporal dementia reveal early stage TDP-43 pathobiology.
    Nana AL; Sidhu M; Gaus SE; Hwang JL; Li L; Park Y; Kim EJ; Pasquini L; Allen IE; Rankin KP; Toller G; Kramer JH; Geschwind DH; Coppola G; Huang EJ; Grinberg LT; Miller BL; Seeley WW
    Acta Neuropathol; 2019 Jan; 137(1):27-46. PubMed ID: 30511086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accumulation of dipeptide repeat proteins predates that of TDP-43 in frontotemporal lobar degeneration associated with hexanucleotide repeat expansions in C9ORF72 gene.
    Baborie A; Griffiths TD; Jaros E; Perry R; McKeith IG; Burn DJ; Masuda-Suzukake M; Hasegawa M; Rollinson S; Pickering-Brown S; Robinson AC; Davidson YS; Mann DM
    Neuropathol Appl Neurobiol; 2015 Aug; 41(5):601-12. PubMed ID: 25185840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C9ORF72 dipeptide repeat poly-GA inclusions promote intracellular aggregation of phosphorylated TDP-43.
    Nonaka T; Masuda-Suzukake M; Hosokawa M; Shimozawa A; Hirai S; Okado H; Hasegawa M
    Hum Mol Genet; 2018 Aug; 27(15):2658-2670. PubMed ID: 29750243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular Mechanisms of Neurodegeneration Related to
    Babić Leko M; Župunski V; Kirincich J; Smilović D; Hortobágyi T; Hof PR; Šimić G
    Behav Neurol; 2019; 2019():2909168. PubMed ID: 30774737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TDP-43 cytoplasmic inclusion formation is disrupted in
    Lee SM; Asress S; Hales CM; Gearing M; Vizcarra JC; Fournier CN; Gutman DA; Chin LS; Li L; Glass JD
    Brain Commun; 2019; 1(1):fcz014. PubMed ID: 31633109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A pathogenic progranulin mutation and C9orf72 repeat expansion in a family with frontotemporal dementia.
    Lashley T; Rohrer JD; Mahoney C; Gordon E; Beck J; Mead S; Warren J; Rossor M; Revesz T
    Neuropathol Appl Neurobiol; 2014 Jun; 40(4):502-13. PubMed ID: 24286341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dipeptide repeat protein and TDP-43 pathology along the hypothalamic-pituitary axis in C9orf72 and non-C9orf72 ALS and FTLD-TDP cases.
    Dedeene L; Van Schoor E; Ospitalieri S; Ronisz A; Weishaupt JH; Otto M; Ludolph AC; Scheuerle A; Vandenberghe R; Van Damme P; Poesen K; Thal DR
    Acta Neuropathol; 2020 Nov; 140(5):777-781. PubMed ID: 32862270
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical and neuropathological features of ALS/FTD with TIA1 mutations.
    Hirsch-Reinshagen V; Pottier C; Nicholson AM; Baker M; Hsiung GR; Krieger C; Sengdy P; Boylan KB; Dickson DW; Mesulam M; Weintraub S; Bigio E; Zinman L; Keith J; Rogaeva E; Zivkovic SA; Lacomis D; Taylor JP; Rademakers R; Mackenzie IRA
    Acta Neuropathol Commun; 2017 Dec; 5(1):96. PubMed ID: 29216908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progressive amnestic dementia, hippocampal sclerosis, and mutation in C9ORF72.
    Murray ME; Bieniek KF; Banks Greenberg M; DeJesus-Hernandez M; Rutherford NJ; van Blitterswijk M; Niemantsverdriet E; Ash PE; Gendron TF; Kouri N; Baker M; Goodman IJ; Petrucelli L; Rademakers R; Dickson DW
    Acta Neuropathol; 2013 Oct; 126(4):545-54. PubMed ID: 23922030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Familial frontotemporal dementia associated with C9orf72 repeat expansion and dysplastic gangliocytoma.
    Ferrari R; Kero M; Mok K; Paetau A; Tienari PJ; Tynninen O; Hardy J; Momeni P; Verkkoniemi-Ahola A; Myllykangas L
    Neurobiol Aging; 2014 Feb; 35(2):444.e11-4. PubMed ID: 24080172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dipeptide repeat protein pathology in C9ORF72 mutation cases: clinico-pathological correlations.
    Mackenzie IR; Arzberger T; Kremmer E; Troost D; Lorenzl S; Mori K; Weng SM; Haass C; Kretzschmar HA; Edbauer D; Neumann M
    Acta Neuropathol; 2013 Dec; 126(6):859-79. PubMed ID: 24096617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frontotemporal lobar dementia and amyotrophic lateral sclerosis associated with c9orf72 expansion.
    Le Ber I
    Rev Neurol (Paris); 2015; 171(6-7):475-81. PubMed ID: 26032484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations.
    Snowden JS; Rollinson S; Thompson JC; Harris JM; Stopford CL; Richardson AM; Jones M; Gerhard A; Davidson YS; Robinson A; Gibbons L; Hu Q; DuPlessis D; Neary D; Mann DM; Pickering-Brown SM
    Brain; 2012 Mar; 135(Pt 3):693-708. PubMed ID: 22300873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aberrant deposition of stress granule-resident proteins linked to C9orf72-associated TDP-43 proteinopathy.
    Chew J; Cook C; Gendron TF; Jansen-West K; Del Rosso G; Daughrity LM; Castanedes-Casey M; Kurti A; Stankowski JN; Disney MD; Rothstein JD; Dickson DW; Fryer JD; Zhang YJ; Petrucelli L
    Mol Neurodegener; 2019 Feb; 14(1):9. PubMed ID: 30767771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical detection of C9orf72 protein in frontotemporal lobar degeneration and motor neurone disease: patterns of immunostaining and an evaluation of commercial antibodies.
    Davidson YS; Robinson AC; Rollinson S; Pickering-Brown S; Xiao S; Robertson J; Mann DMA
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Feb; 19(1-2):102-111. PubMed ID: 28766957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebellar c9RAN proteins associate with clinical and neuropathological characteristics of C9ORF72 repeat expansion carriers.
    Gendron TF; van Blitterswijk M; Bieniek KF; Daughrity LM; Jiang J; Rush BK; Pedraza O; Lucas JA; Murray ME; Desaro P; Robertson A; Overstreet K; Thomas CS; Crook JE; Castanedes-Casey M; Rousseau L; Josephs KA; Parisi JE; Knopman DS; Petersen RC; Boeve BF; Graff-Radford NR; Rademakers R; Lagier-Tourenne C; Edbauer D; Cleveland DW; Dickson DW; Petrucelli L; Boylan KB
    Acta Neuropathol; 2015 Oct; 130(4):559-73. PubMed ID: 26350237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frontotemporal dementia in a Brazilian kindred with the c9orf72 mutation.
    Takada LT; Pimentel ML; Dejesus-Hernandez M; Fong JC; Yokoyama JS; Karydas A; Thibodeau MP; Rutherford NJ; Baker MC; Lomen-Hoerth C; Rademakers R; Miller BL
    Arch Neurol; 2012 Sep; 69(9):1149-53. PubMed ID: 22964910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening for the C9ORF72 repeat expansion in a greek frontotemporal dementia cohort.
    Kartanou C; Karadima G; Koutsis G; Breza M; Papageorgiou SG; Paraskevas GP; Kapaki E; Panas M
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Feb; 19(1-2):152-154. PubMed ID: 29166782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C9orf72-specific phenomena associated with frontotemporal dementia and gastrointestinal symptoms in the absence of TDP-43 aggregation.
    Sampognaro PJ; Vatsavayai SC; Cosme CG; Hwang JL; Nolan A; Huang EJ; Seeley WW; De May MG
    Acta Neuropathol; 2019 Dec; 138(6):1093-1097. PubMed ID: 31624869
    [No Abstract]   [Full Text] [Related]  

  • 40. Serum total TDP-43 levels are decreased in frontotemporal dementia patients with C9orf72 repeat expansion or concomitant motoneuron disease phenotype.
    Katisko K; Huber N; Kokkola T; Hartikainen P; Krüger J; Heikkinen AL; Paananen V; Leinonen V; Korhonen VE; Helisalmi S; Herukka SK; Cantoni V; Gadola Y; Archetti S; Remes AM; Haapasalo A; Borroni B; Solje E
    Alzheimers Res Ther; 2022 Oct; 14(1):151. PubMed ID: 36217158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.